McFarlane Neil F.
Reporting owner on Forms 3, 4 and 5, CIK 1681098.
McFarlane Neil F. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ZVRA · ZEVRA THERAPEUTICS, INC.CIK 1434647 | director, officer (President and CEO) | 1 | 2026-10-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ZVRA · ZEVRA THERAPEUTICS, INC.Common Stock | 2026-10-12 | S sold | -20,000 | $11.2474 | 417,225 | Form 4 |
| ZVRA · ZEVRA THERAPEUTICS, INC.Common Stock | 2026-10-10 | M exercised | +50,000 | 437,225 | Form 4 | |
| ZVRA · ZEVRA THERAPEUTICS, INC.Restricted Stock Unit, derivative | 2026-10-10 | M exercised | -50,000 | $0 | 50,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001434647-26-000075 | ZEVRA THERAPEUTICS, INC. | 2026-10-13 |